Agenus reports Q3 results

* Agenus press release [https://seekingalpha.com/pr/20300189-agenus-reports-q3-2025-results-showcasing-clinical-and-regulatory-advances] (AGEN [https://seekingalpha.com/symbol/AGEN]): Q3 GAAP EPS of $1.94.
* Revenue of $30.2M (+20.3% Y/Y).

MORE ON AGENUS

* Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript [https://seekingalpha.com/article/4831627-agenus-inc-agen-shareholder-analyst-call-transcript]
* Agenus Inc. (AGEN) Virtual Stakeholder Briefing Call Transcript [https://seekingalpha.com/article/4817638-agenus-inc-agen-virtual-stakeholder-briefing-call-transcript]
* Agenus: Cash Starved Pharma Counting On Bot/Bal Cancer Bounty [https://seekingalpha.com/article/4812713-agenus-cash-starved-pharma-counting-on-botbal-cancer-bounty]
* Agenus Q3 2025 Earnings Preview [https://seekingalpha.com/news/4518860-agenus-q3-2025-earnings-preview]
* Seeking Alpha’s Quant Rating on Agenus [https://seekingalpha.com/symbol/AGEN/ratings/quant-ratings]